Navigation Links
AGA Medical Corporation Launches Second Web-Based Stroke Education and Awareness Video Featuring Professional Football Player Tedy Bruschi
Date:2/26/2009

MINNEAPOLIS, Feb. 26 /PRNewswire/ -- AGA Medical Corporation today launched the second in a series of web-based stroke education and awareness videos featuring Tedy Bruschi, a professional football player who suffered a stroke in February 2005, subsequently recovered and returned to his career. The new video features Tedy describing his personal experience while suffering a stroke. The video is a continuation of Tedy's story that began with the first video in the series, posted in late January. It will be followed by additional videos posted monthly on the AGA Medical website that describe Tedy's firsthand experience as a stroke victim, survivor and prevention champion.

"I hope that by sharing my experiences through the video series people will come to understand the important risk factors for stroke, learn to quickly identify the warning signs and be better prepared should they themselves or a loved one, colleague or neighbor experience a stroke," said Tedy Bruschi. "I know firsthand the emotional and physical challenges that experiencing a stroke can lead to. My hope is that the content of the program developed with AGA Medical may help other stroke survivors achieve a positive recovery. That is why this effort is so important to me."

AGA Medical announced its partnership with Tedy Bruschi in December 2008 with the release of a video in which Tedy describes the warning signs of stroke. In January, the national stroke awareness program's next initiative - a series of five inspirational videos of Tedy discussing his personal experience with stroke and educating others about warning signs - kicked off with the release of a video describing Tedy's life prior to his stroke. Each month though May, AGA Medical Corporation and Tedy will team up to release a new video. Visitors to the www.amplatzer.com/strokeawareness website will be able to view all videos released to date. AGA Medical Corporation will launch additional initiatives throughout 2009 to build upon this comprehensive stroke education, awareness and prevention campaign.

"We believe making Tedy's story widely available is an important way to help people at risk for stroke," said John Barr, chief executive officer of AGA Medical. "As we collaborate with physicians around the world to study new therapies that could potentially prevent stroke, we are reminded daily about the need to better educate those at risk."

Stroke, defined as a sudden injury to the brain caused by a blood vessel bursting or becoming blocked, is the nation's number 3 cause of death behind heart disease and cancer. The American Heart Association reports that each year, about 700,000 Americans suffer from a stroke. One-third of stroke victims are under 65, and even children can suffer a stroke.

About Tedy Bruschi

Coming off the success of winning his 3rd league championship and playing in the annual league all-star game in February of 2005, Tedy unexpectedly experienced a stroke. On the advice of his physician, a device from AGA Medical was prescribed and implanted as part of Tedy's treatment. After several months of extensive rehabilitation and recovery, Tedy was medically cleared to resume playing football less than a year later. Today, in addition to his continued success on the field, Tedy dedicates a considerable part of his time off the field toward raising stroke awareness and funds for stroke research.

To learn more about Tedy and the warning signs of stroke, visit www.amplatzer.com/strokeawareness.

Clinical Trial Underway

AGA Medical is currently conducting a multicenter, randomized clinical study, known as the RESPECT trial, to investigate whether closure of a congenital heart defect using an AGA Medical device is superior to current standard of care treatment in the prevention of a particular type of stroke. For more information on the clinical trial and the warning signs of stroke, visit www.amplatzer.com.

About AGA Medical Corporation

AGA Medical Corporation, based in Plymouth, Minnesota, is a leader in developing interventional devices for the minimally invasive treatment of cardiovascular defects and peripheral vascular disease. Founded in 1995 by Dr. Kurt Amplatz, a former professor and researcher at the University of Minnesota Department of Radiology, AGA Medical develops and commercializes devices for a range of structural heart repair and circulatory conditions. Several of these devices have been major innovations in the treatment of the most common congenital "holes in the heart", such as atrial septal defects and patent foramen ovales.

More than 700 articles have been published in medical literature that support the benefits of AGA Medical devices, including improved patient outcomes, reduced length of stay, and accelerated recovery times for the patient. AGA Medical devices have received regulatory approval and are marketed in 101 countries. For more information, visit www.amplatzer.com.


'/>"/>
SOURCE AGA Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete
2. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
3. Millstone Medical Outsourcing Opens New Facility to Provide Additional Capacity for Advanced Inspection, Clean Room Operations
4. Rush University Medical Center experts present latest research findings at AAOS meeting
5. Hospice of Philadelphia Medical Director, Deborah Way, MD, Earns Certification from the American Board of Internal Medicine
6. Lakeside Community Healthcare Continues Growth With Verdugo Hills Medical Group IPA Affiliation
7. Sciemetric makes the grade with major medical device manufacturer
8. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
9. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
10. RBC Life Sciences 2008 Net Sales Increase 13 Percent as Its Nutritional Supplements and Medical Products Brands See Continued Growth
11. More Than Half of Americans Say Family Skimped on Medical Care Because of Cost in Past Year; Worries About Affordability and Availability of Care Rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology: